Perlmutter Cancer Center Education & Research
At NYU Langone Health’s Perlmutter Cancer Center, a National Cancer Institute–designated Comprehensive Cancer Center, our scientists, researchers, and educators are at the forefront of cancer research, education and training, and community outreach. Our basic, translational, clinical, and population-based research program brings together laboratory scientists and clinical researchers to deliver the latest advances in cancer care and a multidisciplinary approach to patient care.
Our investigators perform basic, translational, and clinical research studies to advance discoveries to prevent, diagnose, and treat cancer. We also study the prevention, patterns, causes, and control of cancer in diverse populations to improve public health and policy. NYU Langone’s core research facilities support our investigators by providing expertise in advanced research techniques and state-of-the-art technologies. Together, we are working to cure cancer in our lifetime.
Cancer Clinical Trials
Our Year in Review
Perlmutter Cancer Center on Twitter
Donate and Volunteer
Related News
New Drug Shows Promise in Treating an Aggressive Skin Cancer
New Program Manages the Side Effects of Cancer Treatments
Meet NYU Langone’s New Dean & CEO, Dr. Alec C. Kimmelman
Doctors Pinpoint an Elusive Diagnosis to Save a Patient
What to Know About the Rise of Breast Cancer in Young Adults
Oral Microbes Linked to Increased Risk of Pancreatic Cancer
Two New Cancer Leaders Join Perlmutter Cancer Center
NYU Langone Names New Lead for Blood Cancers
New Approach May Counter Autoimmunity
Existing Drugs May Help Patients with Immunotherapy-Resistant Skin Cancer
Genetic Differences Predict Resistance to Skin Cancer Therapy